The Wellness · Health News
Clinical
Trial results, drug approvals, biotech
4 Jul 2026Why Doctors Choose Medicine—and Whether They Stay
A prize essay published in The Lancet interrogates the motivations and enduring commitment of early-career doctors, set against the lived pressures of modern clinical work.
4 Jul 2026Biopharma Firms Misreading FDA AI Guidance, Says Former Regulator
A former FDA artificial intelligence regulator has argued that biopharma companies are applying the agency's AI guidance more cautiously than the framework requires, while also suggesting the FDA bears some responsibility for the confusion.
- 4 Jul 2026
Biopharma Firms Misread FDA AI Guidance, Says Former Regulator
A former FDA artificial intelligence regulator now working in the biopharma sector contends that pharmaceutical companies are applying the agency's AI guidance with excessive caution — and that the FDA itself bears some responsibility for the confusion.
- 3 Jul 2026
BMA Calls for NHS Cross-Sex Hormone Access at 16–17
The British Medical Association has written to NHS England recommending that 16 and 17 year olds be granted NHS access to cross-sex hormones, opposing a consultation that proposes halting routine prescriptions for under-18s.
- 3 Jul 2026
FDA Peptide Committee Faces Conflict-of-Interest Scrutiny
A forthcoming FDA advisory committee meeting on peptide compounding restrictions has drawn criticism after reports emerged that seven of the panel's new members hold active commercial interests in the peptide supply sector.
- 3 Jul 2026
FDA Peptide Panel Faces Conflict-of-Interest Scrutiny
Seven of the newly appointed members of an FDA advisory committee tasked with reviewing peptide compounding rules reportedly hold financial interests in businesses that supply those same compounds, according to the BMJ.
3 Jul 2026Medicare Proposes Further 340B Drug Payment Cuts
Medicare has proposed additional cuts to hospital payments tied to the 340B drug discount program, according to STAT News, marking another federal attempt to adjust reimbursement under the long-contested policy.
- 3 Jul 2026
Medicare Proposes Fresh Cuts to 340B Drug Payments
Federal health officials have put forward another round of proposed payment reductions tied to the 340B drug discount program, continuing a pattern of recurring policy efforts to limit Medicare reimbursements for participating hospitals.
- 2 Jul 2026
MHRA Issues Guidance on Patient Information Leaflets
The UK Medicines and Healthcare products Regulatory Agency has released guidance setting out legal requirements and design principles for patient information leaflets accompanying medicines.
- 2 Jul 2026
MHRA Issues Guidance on Patient Information Leaflets
The UK Medicines and Healthcare products Regulatory Agency has released guidance addressing both the regulatory framework and design standards that apply to patient information leaflets.
2 Jul 2026Florida Attorney Kyle Diamantas Takes FDA Food Role
A Florida attorney with a limited profile in food policy circles, Kyle Diamantas was appointed by the Trump administration in 2025 to head the FDA's food division, according to reporting by STAT News.
- 2 Jul 2026
Florida Attorney Kyle Diamantas Takes FDA Food Role
A Florida attorney with little prior profile in food policy circles, Kyle Diamantas was appointed by the Trump administration in 2025 to a senior food-focused role at the FDA.
1 Jul 2026Alcohol Industry Lobbying Intensifies as Demand Falls
Despite falling consumer demand, the alcohol industry has intensified its lobbying and influence campaigns — and, according to a STAT News investigation, those efforts appear to be working.
1 Jul 2026FDA Clears Orca Bio T-Cell Therapy for Blood Cancer
Regulators have approved a new T-cell therapy from Orca Bio aimed at reducing a serious immune complication in blood cancer patients receiving stem cell transplants.
1 Jul 2026DNA Test May Let Breast Cancer Patients Skip Chemo
A new international trial has found that a DNA-based test may help determine which breast cancer patients can safely forgo chemotherapy, a finding with potentially wide-reaching implications.
- 30 Jun 2026
MHRA Issues June 2026 Medicines Safety Roundup
The UK medicines regulator has released its periodic safety bulletin for mid-2026, continuing a pattern of routine pharmacovigilance updates that flag emerging concerns across drugs and devices.
30 Jun 2026Amish Population Growth Carries Public Health Weight
The Amish population in the United States could reach nearly 2 million by 2075, a trajectory that researchers and public health observers say carries significant implications for how health systems engage with this community.
- 29 Jun 2026
AI and Flu Vaccine Strain Selection: A Field in Flux
Questions about whether artificial intelligence can meaningfully improve how seasonal influenza vaccine strains are chosen remain unresolved, with researchers continuing to weigh evidence on multiple sides.
28 Jun 2026UK MPs Call for Ban on Sunbed Advertising
A cross-party group of UK MPs has released a report on skin cancer prevention, urging a ban on sunbed advertising and concluding that the majority of cases are avoidable.
- 28 Jun 2026
UK MPs Push for Sunbed Ad Ban in Skin Cancer Report
A cross-party group of UK MPs has released a report concluding that the majority of skin cancer cases are preventable, with a proposed ban on sunbed advertising among its central recommendations.
28 Jun 2026CDC Names Ebola Containment Its Top Priority
The CDC has identified containing the spread of Ebola as its top priority, according to a STAT News Morning Rounds briefing published June 1, 2026.
- 28 Jun 2026
CDC Names Ebola Containment Its Top Priority
The CDC has identified Ebola containment as its leading public health priority, according to reporting by STAT News, amid broader scrutiny of U.S. infectious disease readiness.
- 26 Jun 2026
Six-Month Regimen Tested for Drug-Resistant TB
A pragmatic clinical trial published in the New England Journal of Medicine evaluated a shortened treatment strategy for rifampicin-resistant tuberculosis, a drug-resistant form of the disease that presents significant challenges to global health systems.
- 26 Jun 2026
Minipuberty in Infancy: What Clinicians Should Know
A new article in the New England Journal of Medicine examines minipuberty, a transient period of hormonal activity in early infancy, and its potential clinical significance.
26 Jun 2026BIO 2026: AI Viability and Drug Pricing Dominate Talks
The BIO 2026 conference brought together biotech industry leaders to wrestle with questions around artificial intelligence, drug pricing policy, and the growing influence of Chinese biotech firms.
25 Jun 2026Vaccine Industry Weighs Challenges Against Cautious Hope
Vaccine industry representatives gathered at a major biotech conference this week, describing a challenging operating environment alongside pockets of cautious optimism.
- 25 Jun 2026
cAMPfield Therapeutics Raises $180M Series A for I&I Pipeline
A newly launched San Diego biotech focused on inflammatory and immunology diseases has closed a $180 million Series A funding round, signalling continued investor appetite for the I&I therapeutic space.
24 Jun 2026Immune Reset Trial Puts Lupus Into Remission
A clinical trial has put lupus into remission in patients, with those enrolled reportedly no longer requiring medication to manage the autoimmune disease.
- 24 Jun 2026
Immune Reset Trial Achieves Remission in Lupus Patients
A clinical trial has achieved remission in lupus patients through an immune reset approach, with participants no longer requiring medication to manage the condition.
23 Jun 2026HHS Dispatches Drug for Ebola Clinical Trial
The U.S. Department of Health and Human Services has dispatched a drug intended for use in an Ebola clinical trial, according to a report from STAT News.
- 23 Jun 2026
HHS Dispatches Drug for Ebola Clinical Trial
The U.S. Department of Health and Human Services has dispatched a drug intended for use in an Ebola clinical trial, according to reporting by STAT News.
23 Jun 2026Cass Report Author Backs Puberty Blocker Clinical Trial
Dr Hilary Cass, author of the Cass report on gender medicine for children, has defended a proposed clinical trial on puberty blockers, stating that not proceeding poses a greater risk of harm than moving forward.
23 Jun 2026Pfizer Lung Cancer Drug Falls Short in Clinical Trial
An experimental Pfizer drug intended to replace a standard chemotherapy in a common form of lung cancer did not meet the company's expectations in a clinical trial, according to STAT News.
- 23 Jun 2026
Pfizer Lung Cancer Drug Falls Short in Clinical Trial
An experimental Pfizer drug intended to displace a standard chemotherapy regimen in a common form of lung cancer did not meet the hoped-for results in a clinical trial.
22 Jun 2026UK Melanoma Cases Surpass 20,000 in a Single Year
The number of melanoma cases diagnosed annually in the UK has crossed 20,000 for the first time, according to figures reported by BBC News, marking a record high for the country's most serious form of skin cancer.
- 22 Jun 2026
UK Melanoma Cases Surpass 20,000 for First Time
Annual melanoma diagnoses in the UK have crossed the 20,000 threshold for the first time on record, according to BBC News, signalling a continued upward trend in the country's most serious form of skin cancer.
- 22 Jun 2026
MHRA Sets Out Equality Priorities for 2025–2026
The UK medicines regulator has published its latest equality duty report, covering advances in diversity and inclusion across its regulatory, public-facing, and internal workforce functions.
- 21 Jun 2026
Andes Hantavirus Outbreak on Cruise Ship Spurs mRNA Vaccine Push
An Andes hantavirus outbreak on a cruise ship departing Argentina in May 2026 has been described as epidemiologically unprecedented, drawing fresh attention to the case for single-dose mRNA vaccines against the pathogen.
- 21 Jun 2026
mRNA Vaccine Push Follows Cruise Ship Hantavirus Outbreak
An Andes hantavirus outbreak aboard a Dutch cruise ship in May 2026 has drawn renewed scientific attention to the virus's rare person-to-person transmissibility and the potential role of mRNA vaccines in containing future spread.
21 Jun 2026UK Scientists Race to Develop Bundibugyo Ebola Vaccine
British scientists are working to produce a vaccine against the Bundibugyo species of Ebola — a rare but lethal strain for which no proven immunisation currently exists — with developers suggesting it could be available within months.
- 21 Jun 2026
MHRA Publishes Benefit-Risk Review of Avacopan
The Medicines and Healthcare products Regulatory Agency has published a formal assessment of the benefits and risks associated with avacopan, a treatment for certain rare autoimmune conditions.
- 21 Jun 2026
MHRA Publishes Benefit-Risk Review of Avacopan
The UK Medicines and Healthcare products Regulatory Agency has published a formal review examining the benefits and risks associated with avacopan, a treatment for certain rare autoimmune conditions.
- 20 Jun 2026
Oral GLP-1 Drug Elecoglipron Shows Promise in Phase 2b Trial
A phase 2b randomised trial published in The Lancet found that once-daily oral elecoglipron reduced glycaemia in adults with type 2 diabetes, with a tolerability profile consistent with the GLP-1 drug class.
- 20 Jun 2026
Oral GLP-1 Drug Elecoglipron Shows Promise in Phase 2b Trial
A phase 2b randomised trial published in The Lancet found that once-daily oral elecoglipron reduced glycaemia in adults with type 2 diabetes, with a tolerability profile consistent with its drug class.
20 Jun 2026Eli Lilly Cuts 340B Drug Discounts at Dozens of Hospitals
Eli Lilly has moved to end federally mandated drug price breaks at a small number of hospitals enrolled in the 340B discount program, pointing to those facilities' failure to provide claims data as justification.
- 20 Jun 2026
Eli Lilly Cuts 340B Discounts at Hospitals Over Data Gap
Eli Lilly has moved to strip federally mandated drug discounts from a small group of hospitals enrolled in the 340B program, acting on a previously issued threat over missing claims data.
- 19 Jun 2026
frontMIND Trial Links Tafasitamab Combo to Longer PFS in DLBCL
Adding tafasitamab and lenalidomide to standard R-CHOP chemotherapy significantly extended progression-free survival in high-risk diffuse large B-cell lymphoma, though the combination also raised the rate of serious adverse events.
- 19 Jun 2026
Tafasitamab Combo Improves PFS in High-Risk DLBCL
Adding tafasitamab and lenalidomide to standard R-CHOP chemotherapy significantly extended progression-free survival in high-risk diffuse large B-cell lymphoma, according to a global phase 3 trial published in The Lancet — though the combination also raised safety concerns.
- 18 Jun 2026
UKHSA Issues PGD Template for Flu Vaccines IIV and LAIV
The UK Health Security Agency has released a patient group direction template to support the administration of two types of influenza vaccine as part of the national seasonal flu vaccination programme.
- 18 Jun 2026
UKHSA Issues Updated Flu Vaccine PGD Template
The UK Health Security Agency has released a patient group direction template to support administration of two influenza vaccine types under the national seasonal flu vaccination programme.
17 Jun 2026FDA Shows Openness to Moderna Flu Vaccine Before Advisory Review
Regulators appear open to Moderna's influenza vaccine before a formal advisory committee review, STAT News reports, alongside other notable biotech developments.
16 Jun 2026Genomic Test May Spare Breast Cancer Patients Chemotherapy
A genomic test trialled in breast cancer patients could allow millions to forgo chemotherapy entirely, with researchers reporting near-identical survival outcomes for those treated with hormone therapy alone.
15 Jun 2026Pfizer Has Not Fulfilled Emergency Penicillin Donation Request
Pfizer has not fulfilled a request to donate emergency penicillin to state health agencies, according to STAT News — a measure that was intended to serve as a safeguard against congenital syphilis.
- 13 Jun 2026
Atrasentan Shows Kidney Benefits in IgA Nephropathy Trial
A large phase 3 trial published in The Lancet found that atrasentan reduced proteinuria and helped preserve kidney function in patients with IgA nephropathy over a 2.5-year follow-up period.
- 12 Jun 2026
SPIRIT-ROUTINE Extends Trial Protocol Guidance
A new extension to the widely adopted SPIRIT framework aims to strengthen how researchers design and report randomised controlled trial protocols that draw on cohort and routinely collected data.
- 12 Jun 2026
England Plans One-Off MenB Vaccine Drive for Young People
The UK Health Security Agency has announced a one-off programme to offer a two-dose meningococcal B vaccine to thousands of young people in England, with rollout planned before autumn.
12 Jun 2026Nonprofit Buys Discontinued Cancer Drug to Preserve Access
Blood Cancer United, a nonprofit organization, has acquired the remaining stock of a discontinued investigational cancer drug in an effort to preserve access for patients who depend on the experimental treatment.
11 Jun 2026Synthetic Lethality in Cancer Research May Spur Biotech M&A
Researchers are examining synthetic lethality as a potential cancer treatment strategy, though the science requires substantial further validation before its full implications become clear.
- 11 Jun 2026
PRISMA-C Extends Reporting Standards to Paediatric Reviews
A newly developed reporting checklist aims to address gaps in how systematic reviews of children's health interventions are conducted and communicated, according to a BMJ commentary.
- 9 Jun 2026
MHRA Launches AI Sandbox for Medicines Development
The UK medicines regulator has introduced an AI sandbox initiative intended to speed up drug development, strengthen safety oversight, and reduce dependence on animal testing.